Back to search

Article

Promoter hypomethylation upregulates ANXA2 expression in pancreatic cancer and is associated with poor prognosis.

2022-11-29

Abstract excerpt

Pancreatic cancer (PC) is one of the world's most aggressive and deadly cancers, owing to non-specific early clinical symptoms, late-stage diagnosis, and poor survival. Therefore, it is critical to identify specific biomarkers for its early diagnosis. Annexin A2 (ANXA2) is a calcium-dependent phospholipid-binding protein that has been reported to be up-regulated in several cancer types, making it an emerging bioma...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
b7f685f0-444e-5966-825b-796cd3a26496
DOI
10.21203/rs.3.rs-2306538/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Promoter hypomethylation upregulates ANXA2 expression in pancreatic cancer and is associated with poor prognosis.DOI 10.21203/rs.3.rs-2306538/v1
Select a neighboring publication to make it the new centre.